A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group (Q44348371)
Jump to navigation
Jump to search
scientific article published on 8 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group |
scientific article published on 8 November 2012 |
Statements
1 reference
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group (English)
1 reference
I Ray-Coquard
1 reference
P Pautier
1 reference
A Floquet
1 reference
L Gladieff
1 reference
E Bompas
1 reference
S Piperno-Neumann
1 reference
F Selle
1 reference
C Guillemet
1 reference
B Weber
1 reference
R Largillier
1 reference
F Bertucci
1 reference
P Opinel
1 reference
F Duffaud
1 reference
A Reynaud-Bougnoux
1 reference
C Delcambre
1 reference
N Isambert
1 reference
P Kerbrat
1 reference
G Netter-Pinon
1 reference
N Pinto
1 reference
P Duvillard
1 reference
C Haie-Meder
1 reference
C Lhommé
1 reference
A Rey
1 reference
8 November 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference